根据最新的财务报表(Form-10K),Picard Medical Inc 的总资产为 $12,净损失为 $-23
PMI 的关键财务比率是什么?
Picard Medical Inc 的流动比率是 0.34,净利 margin 为 -575,每股销售为 $0.05。
Picard Medical Inc 的收入按细分市场或地理位置如何划分?
Picard Medical Inc 最大收入来源是 Commercial Banking and Trust,在最近的收益报告中收入为 163,686,000。就地区而言, United States 是 Picard Medical Inc 的主要市场,收入为 163,686,000。
Picard Medical Inc 是否盈利?
不,根据最新的财务报表,Picard Medical Inc 的净损失为 $-23
Picard Medical Inc 有负债吗?
是的,Picard Medical Inc 的负债为 35
Picard Medical Inc 的流通股有多少?
Picard Medical Inc 的总流通股为 72.32
360报告
关键数据
前收盘价
$1.08
开盘价
$1.09
当日区间
$0.9861 - $1.09
52周范围
$0.92 - $13.68
交易量
55.7K
平均成交量
809.9K
股息收益率
--
每股收益(TTM)
--
市值
$74.0M
什么是 PMI?
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. The company is headquartered in Tucson, Arizona and currently employs 75 full-time employees. The company went IPO on 2025-08-29. SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.